ImageneBio Inc(IMA)

Biotechnology · San Diego, CA

$4.81+0.11 (+2.34%)

Delayed quote: Oct 6, 2026, 10:56 AM EDT

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T15:27:22.045Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:27:22.045Z.

Quote observation: 2026-10-06T14:56:10.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 54,252,471
Total debt · period ending 2026-06-30: 1,912,000
Cash · period ending 2026-06-30: 94,677,000
TTM operating EBITDA · period ending 2026-06-30: -57,578,001

FMP input reference: 3f3fe5cfad96663d45aee285232b63282d401ce5a2dce1ebe999e7f7af3a8937

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

IMA EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

IMA Competitors' EV/EBITDA Ratio

IMA

ImageneBio Inc

Current

Market Cap

$54.25M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALDX

Aldeyra The

vs IMA

Market Cap

$54.90M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDAI

Spectral AI, Inc.

vs IMA

Market Cap

$55.21M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELOX

Eloxx Pharmaceuticals, Inc.

vs IMA

Market Cap

$52.37M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DWTX

Dogwood Therapeutics, Inc.

vs IMA

Market Cap

$52.13M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EXOZ

eXoZymes, Inc.

vs IMA

Market Cap

$51.70M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OKYO

OKYO Pharma Limited

vs IMA

Market Cap

$56.98M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

COCH

Envoy Medical, Inc.

vs IMA

Market Cap

$51.33M

EV/EBITDA Ratio

N/A

TTM Avg

335.70x

3Y Avg

335.70x

5Y Avg

335.70x

NMAD

NOMAD Power Solutions, Inc.

vs IMA

Market Cap

$51.66M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CLNN

Clene Inc.

vs IMA

Market Cap

$50.82M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
ImageneBio Inc (IMA)	$54.25M	N/A	N/A	N/A	N/A
Aldeyra The (ALDX)vs ›	$54.90M	N/A	N/A	N/A	N/A
Spectral AI, Inc. (MDAI)vs ›	$55.21M	N/A	N/A	N/A	N/A
Eloxx Pharmaceuticals, Inc. (ELOX)vs ›	$52.37M	N/A	N/A	N/A	N/A
Dogwood Therapeutics, Inc. (DWTX)vs ›	$52.13M	N/A	N/A	N/A	N/A
eXoZymes, Inc. (EXOZ)vs ›	$51.70M	N/A	N/A	N/A	N/A
OKYO Pharma Limited (OKYO)vs ›	$56.98M	N/A	N/A	N/A	N/A
Envoy Medical, Inc. (COCH)vs ›	$51.33M	N/A	335.70x	335.70x	335.70x
NOMAD Power Solutions, Inc. (NMAD)vs ›	$51.66M	N/A	N/A	N/A	N/A
Clene Inc. (CLNN)vs ›	$50.82M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics